Surgery Medical News about Hyperparathyroidism, Primary

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

No recurrence of sporadic primary hyperparathyroidism when cure is established 6 months after parathyroidectomy
European Journal of Endocrinology, 11/05/09

Witteveen J et al. – The cure rate of sporadic primary hyperparathyroidism after initial surgery is 93%. When cure is achieved, this is sustained in 100% of patients for up to 24 years post–operatively. The data suggest that closer early follow–up is advocated in all patients undergoing PTx to definitively establish cure and to provide a safety net for those with residual gland pathology. The data do not support the need for long term follow–up when cure is established 6 months after PTx.

<< Previous
Clinical features, surgical treatment, and long-term outcome in...

Next >>
Endovascular coil embolization of anterior choroidal artery...

Postexercise Cardiac Performance Among Patients With Mild Primary Hyperparathyroidism
The Endocrinologist, 11/16/09 Relevance Score: 68%

Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism
Diabetic Medicine, 10/02/09 Relevance Score: 67%

Nonoperative management of primary hyperparathyroidism: the exception rather than the rule
Expert Review of Endocrinology & Metabolism, 11/17/09 Relevance Score: 66%

Cinacalcet Treatment of Primary Hyperparathyroidism: Biochemical and Bone Densitometric Outcomes in a Five-Year Study
Journal of Clinical Endocrinology and Metabolism, 10/21/09 Relevance Score: 66%

Single Photon Emission Computed Tomography (SPECT) Should be Routinely Performed for the Detection of Parathyroid Abnormalities Utilizing Technetium-99m Sestamibi Parathyroid Scintigraphy
Clinical Nuclear Medicine, 10/07/09 Relevance Score: 66%